Załącznik 380181
Wersja do druku
To pewnie cowboy I znajomy lekarz :senorkekw
a jak szczepilem sie na odre to moge sie w niej kapac?
https://pbs.twimg.com/media/Eh4qqnVX0AE8qgV.jpgCytuj:
ciche ściany napisał
to juz grypa, a nie covid?Cytuj:
W ostatnim tygodniu przedświątecznym mieliśmy blisko 300 tys. zachorowań na grypę. Dziennie jest około 50 tys. zachorowań - mówił minister zdrowia Adam Niedzielski.
Jakieś przejęzyczenie chyba. Covid nie odpuszcza. Mam nadzieje, że wy w święta nosiliście maski i wymagaliście od bliskich dowodu szczepienia i negatywnego testu
Chyba trzeba będzie przeprowadzić sie do Chin, poczuc smak normalnosci
Którą teraz już dawke żydy wszczepiają?
https://www.sciencedirect.com/scienc...1393512201982X
s shown in Appendix Table 3 if 100% of non-elderly people globally were to be infected without having the benefit of vaccination or other potentially beneficial interventions that were developed and implemented later in the pandemic, a total of 4.7–5.3 million deaths of people 0–69 years old are expected worldwide according to our IFR estimates. This includes 32–98 thousand deaths of people 0–29 years old. Three years after the emergence of SARS-CoV-2, the large majority of the global population has indeed been infected at least once (Ioannidis, 2022) and an estimated 44% had been infected even before the advent of the Omicron wave in fall 2021 (COVID-19 Cumulative Infection Collaborators, 2022). If we assume half of the global non-elderly population infected without the benefit of vaccination or other beneficial interventions, this corresponds to 2.3–2.6 million deaths in people 0–69 years old, including 16–49 thousand deaths of people 0–29 years old. These absolute numbers of fatalities are overall probably modestly higher than seasonal flu fatalities over three typical pre-pandemic years (Ioannidis, 2022) when the entire 0–69 year old population is considered, but they are lower than pre-pandemic years when only the younger age strata are considered. For example, Iuliano et al. (2018) estimate 9243–105,690 deaths for children <5 years old per year based on data from 92 countries for seasonal influenza.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813456/
In total, 763 students (17.1%) had at least one cardiac symptom after the second vaccine dose, mostly chest pain and palpitations. The depolarization and repolarization parameters (QRS duration and QT interval) decreased significantly after the vaccine with increasing heart rate. Abnormal ECGs were obtained in 51 (1.0%) of the students, of which 1 was diagnosed with mild myocarditis and another 4 were judged to have significant arrhythmia.
spik polisz plis
https://www.sciencedirect.com/scienc...64410X22010283
Results
Pfizer and Moderna mRNA COVID-19 vaccines were associated with an excess risk of serious adverse events of special interest of 10.1 and 15.1 per 10,000 vaccinated over placebo baselines of 17.6 and 42.2 (95 % CI −0.4 to 20.6 and −3.6 to 33.8), respectively. Combined, the mRNA vaccines were associated with an excess risk of serious adverse events of special interest of 12.5 per 10,000 vaccinated (95 % CI 2.1 to 22.9); risk ratio 1.43 (95 % CI 1.07 to 1.92). The Pfizer trial exhibited a 36 % higher risk of serious adverse events in the vaccine group; risk difference 18.0 per 10,000 vaccinated (95 % CI 1.2 to 34.9); risk ratio 1.36 (95 % CI 1.02 to 1.83). The Moderna trial exhibited a 6 % higher risk of serious adverse events in the vaccine group: risk difference 7.1 per 10,000 (95 % CI –23.2 to 37.4); risk ratio 1.06 (95 % CI 0.84 to 1.33). Combined, there was a 16 % higher risk of serious adverse events in mRNA vaccine recipients: risk difference 13.2 (95 % CI −3.2 to 29.6); risk ratio 1.16 (95 % CI 0.97 to 1.39).
Discussion
The excess risk of serious adverse events found in our study points to the need for formal harm-benefit analyses, particularly those that are stratified according to risk of serious COVID-19 outcomes. These analyses will require public release of participant level datasets.
https://www.frontiersin.org/articles...2.1067943/full
Conclusion: Despite a lot of information regarding cardiac impairment due to SARS-CoV2, our study does not suggest an increased risk for developing clinically significant heart changes during the 1-year follow-up. Based on our results, routine echocardiography and biomarkers collection is currently not recommended after COVID-19 recovery.
I wszystko jasne :feelsokayman